Company Overview and News

0
Stocks edge higher after Fed chair’s ‘dovish’ remarks

10h bworldonline
Shares advanced on Wednesday, July 18, boosted by the positive performance of international markets after United States Federal Reserve Chairman Jerome Powell hinted at more flexible changes in monetary policy.
SVTMF PSKXF AYAAY SM SMIVY SSI SHAK MWP PHSXY PSE MWIDE ALI AYAAF

0
PSE index up on thin trade

22h business.inquirer.net
The local stock barometer managed to slightly firm up on Tuesday but at an alarmingly low value turnout.
ABZPF SMIVY PSKXF SVTMF ABZPY SYBJF PHSXY SM PSE SECB AP

0
PSBank seeks to raise P15B

22h business.inquirer.net
Philippine Savings Bank, the thrift bank arm of the Metrobank group, plans to raise up to P15 billion from an offering of high-yielding deposits.
PSKXF PHSXY PSE PSB

0
Investors turn attention to earnings reports

2018-07-17 bworldonline
THE MAIN INDEX eked out last-minute gains on Tuesday after moving within a tight range as investors await the release of corporate earnings results in the coming weeks.
PSKXF BDOUY AYAAY UVRBY SECB BDOUF BDO MWP SYBJF URC PHSXY PSE MWIDE ALI UVRBF AYAAF

0
GT Capital’s ProFriends inks deal to sell land in Cavite to MPIC arm

2018-07-16 bworldonline
A PROPERTY UNIT of GT Capital Holdings, Inc. has sealed a deal with Metro Pacific Investments Corp.’s (MPIC) logistics arm to sell its Cavite property for P1.02 billion.
GTCXY PSKXF GTCAP PX MPCFF MPCIY MPI PXMFF PHSXY PSE PXMFY

0
FMIC expects PHL stock market to recover in 2018’s second half

2018-07-16 bworldonline
FIRST METRO Investment Corp. (FMIC) expects the local bourse to stage a rebound in the second half of 2018, albeit revising downward its year-end target for the Philippine Stock Exchange index (PSEi) due to higher oil prices, the global trade war, likely rate hikes by the US Federal Reserve, higher domestic inflation and the weakening peso, coupled with some political concerns.
PSKXF PHSXY PSE

0
Bourse caps four-day rally amid lack of leads

2018-07-16 bworldonline
The bellwether Philippine Stock Exchange index (PSEI) snapped its four-day winning streak Monday, July 16, dropping 29.74 points or 0.4% to end at 7,369.44, while the broader all-shares index gave up 12.29 points or 0.27% to finish at 4,462.60.
SVTMF PSKXF BDOUY AYAAY SM BDOUF BDO SMIVY MWP PHSXY PSE MWIDE ALI AYAAF

0
Vitarich bags SEC approval for equity restructuring

2018-07-16 bworldonline
The Securities and Exchange Commission (SEC) has approved the equity restructuring of Vitarich Corp that will allow the firm to wipe out its deficit and declare dividends to shareholders.
PSKXF PHSXY PSE

0
PSEi ends four-day rally

2018-07-16 bworldonline
Local equities slumped on Monday, July 16, as the market continued to consolidate within range due to lack of catalysts.
SVTMF PSKXF BDOUY AYAAY SM BDOUF BDO SMIVY MWP PHSXY PSE MWIDE ALI AYAAF

1
ICTSI eyes port deal in Sudan

2018-07-13 business.inquirer.net
International Container Terminal Services Inc. moved closer to winning a port concession deal in Sudan, a disclosure to the Philippine Stock Exchange showed.
ICT PSKXF PHSXY PSE ICTEF

0
DoubleDragon eyes tag as dividend machine

2018-07-13 business.inquirer.net
Property developer DoubleDragon Properties has completed a P4.3-billion re-initial public offering (IPO), a key component of its goal to transform itself into a “recurring dividend machine” in two years.
PSKXF PHSXY PSE DD

0
PH 7-Eleven operator reports 6-month profit growth of 19.4%

2018-07-13 business.inquirer.net
The country’s leading convenience store operator, Philippine Seven Corp. (PSC), grew its net profit in the first six months by 19.4 percent year-on-year to P533.2 million, citing the favorable impact of recent individual income tax cuts on consumer spending.
PSKXF SEVN PHSXY PSE PHSVY

0
PH stocks gain more ground

2018-07-13 business.inquirer.net
The local stock barometer firmed up for the fourth straight session yesterday, flirting with the 7,400 mark in intra-day trade in line with mostly upbeat regional markets.
PSKXF SYBJF PHSXY PSE SECB

0
Vista Land signs P7.7-B corporate note facility

2018-07-13 bworldonline
VISTA Land & Lifescapes, Inc. (VLL) has secured corporate note facilities totaling P7.7 billion to fund its capital expenditures this year.
PSKXF CHIB SYBJF PHSXY PSE SECB CKGOY

0
TBGI throws hat in ring for 3rd telco slot

2018-07-12 business.inquirer.net
Publicly traded Transpacific Broadband Group International Inc. (TBGI) announced on Thursday it would join the race to become the country’s third major telco player.
ATN PSKXF PHSXY PSE ATNB

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...